Literature DB >> 1825154

Adaptational changes of MHC gene expression and isozyme transition in cardiac overloading.

S Imamura1, R Matsuoka, E Hiratsuka, M Kimura, T Nakanishi, T Nishikawa, Y Furutani, A Takao.   

Abstract

Distribution of cardiac myosin heavy-chain (MHC) isozymes is regulated during development by hemodynamic change and hormonal stimuli. To understand the evolution of cardiac hypertrophy and the underlying processes, the interaction between acute or chronic cardiac over-loading and serum thyroid hormone levels was studied. Biochemical, physiological, and pathological studies were performed using coarctated (Coa) rats with or without administration of thyroid hormone (Thy) and on sham-operated (Sham) rats and normal rats with or without administration of Thy. The results showed that 1) although serum Thy levels in Coa and Sham rats were nearly the same at all timing points, a significant induction of beta-MHC mRNA and isozyme occurred in Coa rats; 2) in Coa rats where Thy was administered, there was no increase in beta-MHC mRNA and isozyme as seen in Coa rats, and this level was nearly the same as in Sham rats, whereas serum Thy levels were significantly high, as in the normals with administration of Thy; and 3) 77 days after surgery, the hypertrophy was completed, judging from pathological findings at this time, and beta-MHC mRNA and isozyme reached similar levels in all groups, except for the normals with administration of Thy. These results demonstrate the following: 1) the MHC isoform transitions induced by pressure overload are not induced by decreases in serum Thy levels, and the regulation of MHC gene expression is responsive to other triggers in addition to Thy; and 2) the first adaptational process of the heart to hemodynamic overload is the MHC isoform transition, and the second adaptational process of that is the hypertrophy itself.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825154     DOI: 10.1152/ajpheart.1991.260.1.H73

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Swimming exercise in infancy has beneficial effect on the hearts in cardiomyopathic Syrian hamsters.

Authors:  Mariko Tatsuguchi; Eriko Hiratsuka; Shuichi Machida; Toshio Nishikawa; Shin-Ichiro Imamura; Satoru Shimizu; Masahiko Nishimura; Issei Komuro; Yoshiyuki Furutani; Michiko Furutani; Hiroaki Nagao; Keiko Komatsu; Hiroshi Kasanuki; Rumiko Matsuoka
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

2.  HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.

Authors:  Jenny Y Y Ooi; Natasha K Tuano; Haloom Rafehi; Xiao-Ming Gao; Mark Ziemann; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2015-05-05       Impact factor: 4.528

3.  Altered myofilament stoichiometry in response to heart failure in a cardioprotective α-myosin heavy chain transgenic rabbit model.

Authors:  Brian A Stanley; David R Graham; Jeanne James; Megan Mitsak; Patrick M Tarwater; Jeff Robbins; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2011-03-01       Impact factor: 3.494

4.  Modification of left ventricular hypertrophy by chronic etomixir treatment.

Authors:  M Turcani; H Rupp
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Ectopic expression of an embryonic skeletal myosin heavy chain in human fetal and Syrian hamster hearts.

Authors:  Susumu Minamisawa; Eriko Hiratsuka; Pilar Ruiz-Lozano; Shuichi Machida; Yoshiyuki Furutani; Masahiko Nishimura; Atsuyoshi Takao; Keiji Yanagisawa; Kazuo Momma; Yasutake Saeki; Rumiko Matsuoka
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

6.  Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium.

Authors:  K Ojamaa; J F Petrie; C Balkman; C Hong; I Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure.

Authors:  Jarmila Machackova; Santosh K Sanganalmath; Vijayan Elimban; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.